Home About ALOXI® Clinical Trials Dosing & Administration About CINV

This site is for Health Care Professionals only.

If you are a Health Care Professional, please Click here to register. If you're not, please ask your doctor for more information.

If you are already registered Click here to enter your user ID and Password.

ALOXI® is a colourless solution for intravenous injection and belongs to a group of medicines known as serotonin (5-HT3) antagonists.

ALOXI® is supplied in a pack of one glass vial, containing 5 ml of solution. Each vial contains one dose.

ALOXI® is used for the prevention of nausea and vomiting associated with cancer chemotherapy.

ALOXI® is a trademark of Helsinn Healthcare SA, Lugano, Switzerland.
The information contained on this website is not intended for residents of the United States of America. If you are a resident of the United States of America seeking information on ALOXI®, please visit www.aloxi.com and choose USA.
Patient Leaflet

HELSINN This site is for European Health Care Professionals only. Last Update: 20.03.2016
Sitemap Privacy Policy Terms of Use